Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Yancheng
Clinical trial register · China

Clinical Trials in Yancheng, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5586 Shanghai 3885 Guangzhou 3356 Hangzhou 1825 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5586 Shanghai3885 Guangzhou3356 Hangzhou1825 Wuhan1342
All 625 locations
Target enrolment
to

Trials with a site in Yancheng

18 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Jiangsu Medical College
Not applicable
84
Yancheng
2027-03
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4
50
Fuyang, Zhengzhou, Zhoukou, Huaian, Yancheng, Meihekou, Shanghai
2026-09-23
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
942
Yancheng, Yangzhou, Xuzhou
2026-07-26
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
1,356
Yancheng, Yangzhou, Xuzhou
2026-07-26
Not yet open
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
Early Phase 1
6
Yancheng, Beijing
2026-07-01
Not yet open
China National Biotec Group Company Limited
Observational
600
Suzhou, Handan, Yancheng, Hanzhong, Yuncheng, Mianyang
2026-01-30
Not yet open
Yun Qian
Not applicable
248
Jinjiang, Yancheng, Shanghai
2025-08-01
Not yet open
Yun Qian
Not applicable
318
Jinjiang, Yancheng, Shanghai
2025-07-15
Recruiting
Allogeneic UCB-derived CAR-T for SLE
NCT07274059SLE - Systemic Lupus Erythematosus
Chengdu Ucello Biotechnology Co., Ltd.
Early Phase 1
48
Yancheng, Chengdu
2025-03-26
Recruiting
Effect of Aerobic Exercise With Synchronous Music on Functions Among Medical Students
NCT06788106Psychological Stress, Aerobic Exercise, Medical Students
Universiti Sains Malaysia
Not applicable
134
Yancheng
2025-02-26
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
122
Nanjing, Xuzhou, Yancheng
2024-09-20
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
112
Changzhou, Nanjing, Nantong, Taizhou, Yancheng
2024-05-01
Active, closed
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
NCT06243666Cervical Intraepithelial Neoplasia, Cervical Cancer, Persistent Infection
Xiamen University
Observational
2,188
Yancheng
2024-02-20
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
BeOne Medicines
Phase 2
114
Xiamen, Guangzhou, Zhengzhou, Wuhan, Yancheng, Shenyang, Qingdao, Shanghai
2023-10-23
Recruiting
Multicenter Study of Fulminant Type 1 Diabetes in China
NCT05593081Diabetes Mellitus, Type 1
Second Xiangya Hospital of Central South University
Observational
240
Quanzhou, Guangzhou, Nanning, Zunyi, Haikou, Changsha, Yancheng, Nanchang
2022-05-20
Active, closed
Yancheng First People's Hospital
Phase 2
50
Yancheng
2021-11-15
Active, closed
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer
NCT04807166Ovarian Neoplasms, Fallopian Tube Neoplasms, Neoplasms by Site, Genital Neoplasms, Female
Wenjun Cheng
Phase 2
56
Huai'an, Nanjing, Suzhou, Wuxi, Yancheng
2021-08-24
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
690
Hefei, Nanyang, Nantong, Xuzhou, Yancheng, Jinan, Shanghai, Hangzhou
2019-10-01
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/yancheng

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Yancheng.

How many clinical trials are recruiting in Yancheng?

9 of the 18 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 5 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yancheng), 18 studies
PhaseStudiesRecruitingShare
Not applicable7438.9%
Observational4222.2%
Phase 24122.2%
Early Phase 12111.1%
Phase 4115.6%

Most active sponsors

Lead sponsors with the most studies (Yancheng)
Lead sponsorStudiesRecruiting
Jiangsu Taizhou People's Hospital22
The First Affiliated Hospital with Nanjing Medical University22
Yun Qian20
BeOne Medicines10
Chengdu Ucello Biotechnology Co., Ltd.11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.11
China National Biotec Group Company Limited10
Jiangsu Medical College10
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China10
Second Xiangya Hospital of Central South University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.